Serum biomarkers of hepatocellular carcinoma in patients with liver cirrhosis: a narrative review

Study of the Serum Level of Annexin A5 as a Marker for Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis Patients

Study of Serum Golgi Protein 73 Level as a Marker for Diagnosis of Hepatocellular Carcinoma

Serum Level of Golgi Protein 73 as a Tumor Marker in Patients with Hepatocellular Carcinoma and Hepatitis C Virus-Related Liver Cirrhosis

Serum Lactadherin as a Diagnostic Biomarker in Hepatitis C Virus Cirrhotic Patients with and without Hepatocellular Carcinoma

Assessment of Alpha-1-Acid Glycoprotein as a new Biomarker for Hepatocellular Carcinoma

SERUM LEVEL OF HEPCIDIN IN CIRRHOTIC PATIENTS AS A MARKER FOR HEPATOCELLULAR CARCINOMA

Significance of Serum Hepatocyte Growth Factor Level in Diagnosis of Hepatocellular Carcinoma

SERUM INTERLEUKIN-22 AS A MARKER OF DECOMPENSATED LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN CHRONIC HCV PATIENTS

Corroboration of Serum Apolipoprotein J (Clusterin) as a Biomarker for Evaluating Hepatocellular Carcinoma